NSE filing, NSE: ZENITHDRUG. Summary written from the filing by ALFA Finder's alert engine.
Zenith Drugs Ltd: key numbers
- Share price
- ₹37.00
- Market cap
- ₹63.45 Cr
- Revenue (annual)
- ₹171.2 Cr
- Net profit (annual)
- ₹3.94 Cr
- P/E (TTM)
- 16.1×Sector 46.1×
- Promoter holding
- 69.98%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenith Drugs Ltd
All →Zenith Drugs Business Update
Zenith Drugs Board approved sale of a 5-hectare property in Indore for ₹13.75 Crore to ACE Engineering & Chemicals Pvt Ltd. Completion expected by November 2026.
- Value
- ₹13.75 Cr
Zenith Drugs Bags New Order from Haryana Medical Services Corporation Limited
Zenith Drugs Limited has been awarded a tender by Haryana Medical Services Corporation Limited to supply medicines for two years at Rs. 11.15 per unit.
- From
- Haryana Medical Services Corporation Limited
- Execution
- 2 years
Zenith Drugs Annual General Meeting
Zenith Drugs Limited released the voting results and Scrutinizer's Report for its 26th Annual General Meeting conducted on September 29, 2026.
Zenith Drugs Annual General Meeting
Zenith Drugs Limited has issued a notice for its 26th Annual General Meeting scheduled for September 29, 2026, to transact various ordinary and special business.
Zenith Drugs Capital Structure Change
Zenith Drugs Limited's board approved the allotment of 16,09,050 convertible warrants to promoters on a preferential basis. The aggregate consideration for this issuance is Rs. 6.99 Crore.
- Value
- ₹7.00 Cr
Zenith Drugs Annual General Meeting
Zenith Drugs Limited held an EGM on July 23, 2026. Members considered the issuance of up to 16,09,050 fully convertible warrants to promoters.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.